Skip to main content

Advertisement

Log in

Response of plasma 1,25-dihydroxyvitamin D in the human PTH(1–34) infusion test: An improved index for the diagnosis of idiopathic hypoparathyroidism and pseudohypoparathyroidism

  • Clinical Investigations
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Summary

Synthetic human parathyroid hormone (1–34) (hPTH(1–34) infusion test has been utilized in the differential diagnosis of hypoparathyroidism by examining the incremental response of urinary phosphate and cyclic adenosine monophosphate (AMP). The response of plasma levels of 1,25-dihydroxyvitamin D (1,25(OH)2D) in parathyroid hormone (PTH) infusion test was studied as a new criterion for the differential diagnosis of idiopathic hypoparathyroidism (IHP) and pseudohypoparathyroidism (PHP). Fourteen patients with IHP, 4 patients with PHP, and five control subjects were studied. All subjects received an intravenous infusion of 30 μg hPTH(1–34) over 5 minutes. The basal levels of plasma 1,25(OH)2D in patients with IHP and PHP were significantly lower than those in control subjects, but there was no significant difference between the levels in patients with IHP and in patients with PHP. The plasma levels of 1,25(OH)2D increased after the infusion of hPTH(1–34) and reached a peak 6 to 24 hours afterward. The 1,25(OH)2D increase at 24 hours after the infusion (Δ1,25(OH)2D) in control subjects and in patients with IHP were 18.1±3.91 (mean±SEM) and 24.1±2.80 pg/ml, respectively. There was no significant increase in patients with PHP (Δ1,25(OH)2D=4.9±1.97 pg/ml). From these results, the measurement of Δ1,25(OH)2D in hPTH(1–34) infusion test is useful as a criterion for the differential diagnosis of hypoparathyroidism.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Garabedian M, Holick MF, DeLuca HF, Boyle IT (1972) Control of 25-hydroxycholecalciferol metabolism by parathyroid glands. Proc Natl Acad Sci USA 69:1673–1676

    Article  PubMed  CAS  Google Scholar 

  2. DeLuca HF (1977) Vitamin D metabolism. Clin Endocrinol 7(suppl):1s-17s

    Google Scholar 

  3. Horiuchi N, Suda T, Takahashi H, Shimazawa E, Ogata E (1977)In vivo evidence for the intermediary role of 3′,5′-cyclic AMP in parathyroid hormone-induced stimulation of 1α,25-dihydroxy-vitamin D3 synthesis in rats. Endocrinology 101:969–974

    PubMed  CAS  Google Scholar 

  4. Haussler MR, McCain TA (1977) Basic and clinical concepts related to vitamin D metabolism and action (first of two parts). N Engl J Med 297(18):974–983

    Article  PubMed  CAS  Google Scholar 

  5. Lund BJ, Sørensen OH, Lund BI, Bishop JE, Norman AW (1980) Vitamin D metabolism in hypoparathyroidism. J Clin Endocrinol Metab 51:606–610

    Article  PubMed  CAS  Google Scholar 

  6. Aarskog D, Aksnes L (1980) Acute response of plasma 1,25-dihydroxyvitamin D to parathyroid hormone. Lancet 1:362–363

    Article  PubMed  CAS  Google Scholar 

  7. Slovik DM, Daly MA, Potts JT Jr, Neer RM (1984) Renal 1,25-dihydroxyvitamin D, phosphaturic, and cyclic-AMP responses to intravenous synthetic human parathyroid hormone-(1–34) administration in normal subjects. Clin Endocrinol 20:369–375

    CAS  Google Scholar 

  8. Lambert PW, Hollis BW, Bell NH, Epstein S (1980) Demonstration of a lack of change in serum 1α-dihydroxyvitamin D response to parathyroid extract in pseudohypoparathyroidism. J Clin Invest 66:782–791

    Article  PubMed  CAS  Google Scholar 

  9. Unakami H, Furukawa Y, Sohn HE, Yumita S, Miura R, Hanew K, Yoshinaga K (1982b) Stimulation of 1,25-dihydroxyvitamin D production by parathyroid hormone and dibutyryl 3′,5′-cyclic AMP in normal subjects, hypoparathyroidism and pseudohypoparathyroidism. Tohoku J Exp Med 138:167–175

    Article  PubMed  CAS  Google Scholar 

  10. Ogata E, Yamamoto M, Matsumoto T, Fujita T, Fukase M, Kinoshita Y, Furukawa Y, Sohn HE, Nakajima H, Yasuda T (1984) Standard procedure and the diagnostic criteria for the Ellsworth-Howard test using human PTH(1–34). Folia Endocrinol Jpn 60:971–984 (in Japanese)

    CAS  Google Scholar 

  11. Yumita S, Sohn HE, Miura R, Furukawa Y (1983) The fundamental and clinical studies on human parathyroid hormone radioimmunoassay kit. Horumon To Rinshou 31:233–238 (in Japanese)

    CAS  Google Scholar 

  12. Sohn HE, Furukawa Y, Yumita S, Miura R, Yoshinaga K, Yamane R (1985) Scrutinization of direct assay method for plasma cyclic AMP and clinical applications of nephrogenous cyclic AMP. Folia Endocrinol Jpn 61:912–923 (in Japanese)

    CAS  Google Scholar 

  13. Unakami H (1982) Plasma vitamin D metabolites in parathyroid diseases. Folia Endocrinol Jpn 58:234–247 (in Japanese)

    CAS  Google Scholar 

  14. Miura R, Furukawa Y, Yumita S, Sohn HE, Mizunashi K, Yoshinaga K (1987) 25-Hydroxyvitamin D3 loading test in primary hyperparathyroidism hypoparathyroidism and pseudohypoparathyroidism. Endocrinol Jpn 34:97–104

    PubMed  CAS  Google Scholar 

  15. Levine MA, Downs RW Jr, Moses AM, Breslau NA, Marx SJ, Lasker RD, Rizzoli RE, Aurbach GD, Spiegel AM (1983) Resistance to multiple hormones in patients with pseudohypoparathyroidism. Am J Med 74:545–556

    Article  PubMed  CAS  Google Scholar 

  16. Sohn HE, Furukawa Y, Yumita S, Miura R, Unakami H, Yoshinaga K (1984) Effect of synthetic 1–34 fragment of human parathyroid hormone on plasma adenosine 3′,5′-monophosphate (cAMP) concentration and the diagnostic criteria based on the plasma cAMP response in Ellsworth-Howard test. Endocrinol Jpn 31:33–40

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Miura, R., Yumita, S., Yoshinaga, K. et al. Response of plasma 1,25-dihydroxyvitamin D in the human PTH(1–34) infusion test: An improved index for the diagnosis of idiopathic hypoparathyroidism and pseudohypoparathyroidism. Calcif Tissue Int 46, 309–313 (1990). https://doi.org/10.1007/BF02563821

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02563821

Key words

Navigation